vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and LCNB CORP (LCNB). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $23.9M, roughly 1.8× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -227.5%, a 251.2% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 15.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
GRAL vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $23.9M |
| Net Profit | $-99.2M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -285.4% | 29.2% |
| Net Margin | -227.5% | 23.7% |
| Revenue YoY | 14.0% | 5.1% |
| Net Profit YoY | -2.2% | -7.6% |
| EPS (diluted) | $-2.37 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $23.9M | ||
| Q3 25 | $36.2M | $23.8M | ||
| Q2 25 | $35.5M | $22.8M | ||
| Q1 25 | $31.8M | $21.5M | ||
| Q4 24 | $38.3M | $22.7M | ||
| Q3 24 | $28.7M | $21.4M | ||
| Q2 24 | $32.0M | $19.3M | ||
| Q1 24 | $26.7M | $17.8M |
| Q4 25 | $-99.2M | $5.7M | ||
| Q3 25 | $-89.0M | $6.9M | ||
| Q2 25 | $-114.0M | $5.9M | ||
| Q1 25 | $-106.2M | $4.6M | ||
| Q4 24 | $-97.1M | $6.1M | ||
| Q3 24 | $-125.7M | $4.5M | ||
| Q2 24 | $-1.6B | $925.0K | ||
| Q1 24 | $-218.9M | $1.9M |
| Q4 25 | -285.4% | 29.2% | ||
| Q3 25 | -346.2% | 35.6% | ||
| Q2 25 | -446.9% | 31.6% | ||
| Q1 25 | -482.5% | 25.6% | ||
| Q4 24 | -358.0% | 32.9% | ||
| Q3 24 | -640.5% | 24.9% | ||
| Q2 24 | -5133.8% | 4.9% | ||
| Q1 24 | -851.1% | 12.5% |
| Q4 25 | -227.5% | 23.7% | ||
| Q3 25 | -245.8% | 29.1% | ||
| Q2 25 | -320.7% | 26.0% | ||
| Q1 25 | -333.6% | 21.4% | ||
| Q4 24 | -253.8% | 27.0% | ||
| Q3 24 | -438.7% | 21.2% | ||
| Q2 24 | -4958.8% | 4.8% | ||
| Q1 24 | -819.3% | 10.7% |
| Q4 25 | $-2.37 | $0.40 | ||
| Q3 25 | $-2.46 | $0.49 | ||
| Q2 25 | $-3.18 | $0.41 | ||
| Q1 25 | $-3.10 | $0.33 | ||
| Q4 24 | $-1.49 | $0.44 | ||
| Q3 24 | $-3.94 | $0.31 | ||
| Q2 24 | $-51.06 | $0.07 | ||
| Q1 24 | $-7.05 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $2.6B | $273.9M |
| Total Assets | $2.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $21.6M | ||
| Q3 25 | $126.9M | $35.9M | ||
| Q2 25 | $127.4M | $49.8M | ||
| Q1 25 | $133.9M | $37.7M | ||
| Q4 24 | $214.2M | $35.7M | ||
| Q3 24 | $853.6M | $39.4M | ||
| Q2 24 | $958.8M | $34.9M | ||
| Q1 24 | $199.7M | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $2.6B | $273.9M | ||
| Q3 25 | $2.2B | $269.9M | ||
| Q2 25 | $2.3B | $263.5M | ||
| Q1 25 | $2.4B | $258.7M | ||
| Q4 24 | $2.5B | $253.0M | ||
| Q3 24 | $2.6B | $253.2M | ||
| Q2 24 | $2.7B | $245.2M | ||
| Q1 24 | — | $233.7M |
| Q4 25 | $2.9B | $2.2B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.7B | $2.3B | ||
| Q1 25 | $2.8B | $2.3B | ||
| Q4 24 | $3.0B | $2.3B | ||
| Q3 24 | $3.1B | $2.3B | ||
| Q2 24 | $3.3B | $2.4B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $34.4M |
| Free Cash FlowOCF − Capex | $-63.9M | $33.4M |
| FCF MarginFCF / Revenue | -146.5% | 140.2% |
| Capex IntensityCapex / Revenue | 0.2% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $34.4M | ||
| Q3 25 | $-63.2M | $14.0M | ||
| Q2 25 | $-77.0M | $5.5M | ||
| Q1 25 | $-95.0M | $2.2M | ||
| Q4 24 | — | $93.2M | ||
| Q3 24 | $-104.6M | $11.9M | ||
| Q2 24 | $-171.8M | $54.9M | ||
| Q1 24 | $-207.3M | $-11.9M |
| Q4 25 | $-63.9M | $33.4M | ||
| Q3 25 | $-63.6M | $13.7M | ||
| Q2 25 | $-77.3M | $5.2M | ||
| Q1 25 | $-95.1M | $2.1M | ||
| Q4 24 | — | $89.4M | ||
| Q3 24 | $-105.6M | $10.5M | ||
| Q2 24 | $-173.2M | $53.8M | ||
| Q1 24 | $-209.8M | $-12.8M |
| Q4 25 | -146.5% | 140.2% | ||
| Q3 25 | -175.8% | 57.4% | ||
| Q2 25 | -217.6% | 23.0% | ||
| Q1 25 | -298.6% | 10.0% | ||
| Q4 24 | — | 394.0% | ||
| Q3 24 | -368.4% | 49.0% | ||
| Q2 24 | -541.7% | 278.6% | ||
| Q1 24 | -785.3% | -71.8% |
| Q4 25 | 0.2% | 4.0% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | — | 16.7% | ||
| Q3 24 | 3.4% | 6.7% | ||
| Q2 24 | 4.3% | 5.9% | ||
| Q1 24 | 9.5% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
LCNB
Segment breakdown not available.
